A case of sweat-gland carcinoma with neuroendocrine differentiation

por Koizumi, Shigeru, Togawa, Yaei, Takashi, Inozume, Nakano, Michiyo
Publicado 2022

A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy

por Hanawa, Fumie, Inozume, Takashi, Harada, Kazutoshi, Kawamura, Tatsuyosi, Shibagaki, Naotaka, Shimada, Shinji
Publicado 2011

Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses

por Yaguchi, Tomonori, Kobayashi, Asuka, Inozume, Takashi, Morii, Kenji, Nagumo, Haruna, Nishio, Hiroshi, Iwata, Takashi, Ka, Yuyo, Katano, Ikumi, Ito, Ryoji, Ito, Mamoru, Kawakami, Yutaka
Publicado 2017

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)(V600E) Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

por Yokomichi, Hiroshi, Inozume, Takashi, Wada, Makoto, Asai, Jun, Igaki, Hiroshi, Namikawa, Kenjiro, Hayashi, Ayato, Fukushima, Satoshi, Fujimura, Taku, Koga, Hiroshi, Nakamura, Yasuhiro, Mochizuki, Mie, Yamagata, Zentaro
Publicado 2020

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)

por Yamazaki, Naoya, Takenouchi, Tatsuya, Fujimoto, Manabu, Ihn, Hironobu, Uchi, Hiroshi, Inozume, Takashi, Kiyohara, Yoshio, Uhara, Hisashi, Nakagawa, Kazuhiko, Furukawa, Hiroshi, Wada, Hidefumi, Noguchi, Kazuo, Shimamoto, Takashi, Yokota, Kenji
Publicado 2017

Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study

por Yokota, Kenji, Uchi, Hiroshi, Uhara, Hisashi, Yoshikawa, Shusuke, Takenouchi, Tatsuya, Inozume, Takashi, Ozawa, Kentaro, Ihn, Hironobu, Fujisawa, Yasuhiro, Qureshi, Anila, de Pril, Veerle, Otsuka, Yasushi, Weber, Jeffrey, Yamazaki, Naoya
Publicado 2019

Immunotherapy with 4-1BBL-Expressing iPS Cell‐Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma

por Kuriyama, Haruka, Fukushima, Satoshi, Kimura, Toshihiro, Kanemaru, Hisashi, Miyashita, Azusa, Okada, Etsuko, Kubo, Yosuke, Nakahara, Satoshi, Tokuzumi, Aki, Nishimura, Yuki, Kajihara, Ikko, Makino, Katsunari, Aoi, Jun, Masuguchi, Shinichi, Tsukamoto, Hirotake, Inozume, Takashi, Zhang, Rong, Nakatsura, Tetsuya, Uemura, Yasushi, Senju, Satoru, Ihn, Hironobu
Publicado 2021

TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment

por Kawashima, Shusuke, Inozume, Takashi, Kawazu, Masahito, Ueno, Toshihide, Nagasaki, Joji, Tanji, Etsuko, Honobe, Akiko, Ohnuma, Takehiro, Kawamura, Tatsuyoshi, Umeda, Yoshiyasu, Nakamura, Yasuhiro, Kawasaki, Tomonori, Kiniwa, Yukiko, Yamasaki, Osamu, Fukushima, Satoshi, Ikehara, Yuzuru, Mano, Hiroyuki, Suzuki, Yutaka, Nishikawa, Hiroyoshi, Matsue, Hiroyuki, Togashi, Yosuke
Publicado 2021

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, mu...

por Nakamura, Y., Namikawa, K., Yoshikawa, S., Kiniwa, Y., Maekawa, T., Yamasaki, O., Isei, T., Matsushita, S., Nomura, M., Nakai, Y., Fukushima, S., Saito, S., Takenouchi, T., Tanaka, R., Kato, H., Otsuka, A., Matsuya, T., Baba, N., Nagase, K., Inozume, T., Fujimoto, N., Kuwatsuka, Y., Onishi, M., Kaneko, T., Onuma, T., Umeda, Y., Ogata, D., Takahashi, A., Otsuka, M., Teramoto, Y., Yamazaki, N.
Publicado 2021

Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients

por Mori, Tatsuhiko, Namikawa, Kenjiro, Yamazaki, Naoya, Kiniwa, Yukiko, Yamasaki, Osamu, Yoshikawa, Shusuke, Inozume, Takashi, Kato, Hiroshi, Nakai, Yasuo, Fukushima, Satoshi, Takenouchi, Tatsuya, Maekawa, Takeo, Matsushita, Shigeto, Otsuka, Atsushi, Nomura, Motoo, Baba, Natsuki, Isei, Taiki, Saito, Shintaro, Fujimoto, Noriki, Tanaka, Ryo, Kaneko, Takahide, Kuwatsuka, Yutaka, Matsuya, Taisuke, Nagase, Kotaro, Onishi, Masazumi, Onuma, Takehiro, Nakamura, Yasuhiro
Publicado 2023

Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

por Morinaga, Takao, Inozume, Takashi, Kawazu, Masahito, Ueda, Youki, Sax, Nicolas, Yamashita, Kazuo, Kawashima, Shusuke, Nagasaki, Joji, Ueno, Toshihide, Lin, Jason, Ohara, Yuuki, Kuwata, Takeshi, Yukami, Hiroki, Kawazoe, Akihito, Shitara, Kohei, Honobe-Tabuchi, Akiko, Ohnuma, Takehiro, Kawamura, Tatsuyoshi, Umeda, Yoshiyasu, Kawahara, Yu, Nakamura, Yasuhiro, Kiniwa, Yukiko, Morita, Ayako, Ichihara, Eiki, Kiura, Katsuyuki, Enokida, Tomohiro, Tahara, Makoto, Hasegawa, Yoshinori, Mano, Hiroyuki, Suzuki, Yutaka, Nishikawa, Hiroyoshi, Togashi, Yosuke
Publicado 2022

Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)

por Namikawa, Kenjiro, Ito, Takamichi, Yoshikawa, Shusuke, Yoshino, Koji, Kiniwa, Yukiko, Ohe, Shuichi, Isei, Taiki, Takenouchi, Tatsuya, Kato, Hiroshi, Mizuhashi, Satoru, Fukushima, Satoshi, Yamamoto, Yosuke, Inozume, Takashi, Fujisawa, Yasuhiro, Yamasaki, Osamu, Nakamura, Yasuhiro, Asai, Jun, Maekawa, Takeo, Funakoshi, Takeru, Matsushita, Shigeto, Nakano, Eiji, Oashi, Kohei, Kato, Junji, Uhara, Hisashi, Miyagawa, Takuya, Uchi, Hiroshi, Hatta, Naohito, Tsutsui, Keita, Maeda, Taku, Matsuya, Taisuke, Yanagisawa, Hiroto, Muto, Ikko, Okumura, Mao, Ogata, Dai, Yamazaki, Naoya
Publicado 2023